Psoriasis: Epidemiology, clinical features, co-morbidities, and clinical scoring
Open Access
- 1 January 2016
- journal article
- iadvl -sig-psoriasis-symposium
- Published by Medknow in Indian Dermatology Online Journal
- Vol. 7 (6), 471-480
- https://doi.org/10.4103/2229-5178.193906
Abstract
On the basis of current evidence derived from hospital-based studies, mostly from North India, the prevalence of psoriasis in adults varies from 0.44 to 2.8%, with a much lower prevalence in children. The peak age at onset in adults is in the third and fourth decade of life, with a slight male preponderance. It is recommended that population-based large epidemiologic studies should be undertaken in different parts of the country for estimating the correct prevalence of psoriasis in general population. Chronic plaque-type psoriasis is the most common morphologic presentation of psoriasis, accounting for more than 90% of all cases. Other morphologic variants that deserve special mention include palmoplantar psoriasis, pustular psoriasis, and recalcitrant psoriasis.For epidemiologic purposes, psoriasis can be classified into early and late onset psoriasis. Psoriasis can be classified on the basis of morphology and extent of involvement into localized and widespread disease.For the purpose of clinical trials, psoriasis may be classified as mild psoriasis, moderate psoriasis, and severe psoriasis. The literature shows that there is a significant risk of psoriatic arthritis (7–48%) in patients with plaque-type psoriasis. Hence, it is recommended to evaluate for its presence by detailed history taking and clinical examination, and if necessary, by appropriate radiological investigations. Evidence on the association between plaque-type psoriasis and cardiovascular disease risk factors and ischemic heart disease isinconsistent.On the basis ofavailable evidence, it is prudent to proactively look for metabolic syndrome, dyslipidemia, and obesity, especially in patientswith severe psoriasis (Level 1+ evidence based on systematic reviews and meta-analysis). Based on the current evidence, the psoriasis area severity index appears to be the most valid and reproducible clinical severity score in the management of adult patients with plaque-type psoriasis.Keywords
This publication has 65 references indexed in Scilit:
- Prevalence of metabolic syndrome and cardiovascular changes in patients with chronic plaque psoriasis and their correlation with disease severity: A hospital-based cross-sectional studyIndian Journal of Dermatology, Venereology and Leprology, 2016
- Psoriasis and metabolic syndrome: A systematic review and meta-analysis of observational studiesJournal of the American Academy of Dermatology, 2013
- Erectile dysfunction in patients with psoriasis: increased prevalence, an unmet need, and a chance to interveneBritish Journal of Dermatology, 2010
- What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literatureJournal of the European Academy of Dermatology and Venereology, 2010
- Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studiesJournal of the European Academy of Dermatology and Venereology, 2010
- Axial Psoriatic Arthritis: Update on a Longterm Prospective StudyThe Journal of Rheumatology, 2009
- Psoriatic arthritis in Reykjavik, Iceland: prevalence, demographics, and disease course.2007
- National Psoriasis Foundation Clinical Consensus on Disease SeverityArchives of Dermatology, 2007
- Clinical profile of psoriasis in North India.1995
- PSORIASIS IN THE TROPICS: AN EPIDEMIOLOGICAL SURVEY.1963